Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-26

Clinical Trial Update: Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports an examination of how liraglutide influences the mode of action of insulin detemir in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin detemir (insulin detemir)
  • liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED